COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,440 Articles (22,835 medRxiv, 8,605 bioRxiv)

Most recent first Previous |  Page 536: Articles 5351-5360  | Next

Impact of COVID-19 pandemic on cancer screening in Denmark: A register-based study
Nonboe, M. H., Napolitano, G., Schroll, J. B., Vejborg, I., Waldstroem, M., Lynge, E.
10.1101/2023.01.03.22277971 — Posted: 2023-01-11
Genetic determinants of severe COVID-19 in young Asian and Middle Eastern patients
Badla, B., Hanifa, M., Jain, R., El Naofal, M., Halabi, N., Yaslam, S., Ramaswamy, S., Taylor, A., Al Falasi, R., Shenbagam, S., Khansaheb, H., Al Suwaidi, H., Nowotny, N., Popatia, R., Alsheikh-Ali, A., Al Khayat, A., Loney, T., Al Dabal, L., Abou Tayoun, A. N.
10.1101/2023.01.11.23284427 — Posted: 2023-01-11
Effectiveness of an eHealth Intervention for Reducing Psychological Distress and Increasing COVID-19 Knowledge and Protective Behaviors among Ethnoracially Diverse Sexual and Gender Minority Adults: A Quasi-experimental Study (#SafeHandsSafeHearts)
Newman, P. A., Chakrapani, V., Massaquoi, N., Williams, C. C., Tharao, W., Tepjan, S., Roungprakhon, S., Forbes, J., Sebastian, S., Akkakanjanasupar, P., Aden, M.
10.1101/2023.01.09.23284380 — Posted: 2023-01-11
Validation of a MALDI-TOF MS method for SARS-CoV-2 detection on the Bruker Biotyper and nasopharyngeal swabs. A Brazil - UK collaborative study.
Lovison, O. v. A., Grigaite, R., Zempulski Volpato, F. C., Iles, J. K., Lacey, J., Barreto, F., Pandiri, S. R., Balzan, L. d. L. R., Cantarelli, V. V., Barth, A. L., Martins, A. F., Iles, R. K.
10.1101/2023.01.09.23284367 — Posted: 2023-01-11
Fully Quantitative Measurements of Differential Antibody Binding to a Spectrum of SARS-CoV-2 Spike Proteins: Wuhan, Alpha, Beta, Gamma, Delta, Omicron BA.1, BA.4, BA.5, BA.2.75 and BA.2.12.1
James-Pemberton, P., Kohli, S., Westlake, A., Antill, A., Hunt, J., Olkhov, R., Shaw, A.
10.1101/2023.01.11.23284431 — Posted: 2023-01-11
The impacts of COVID-19 and its policy response on access and utilization of maternal and child health services in Tanzania: a mixed methods study
Shayo, E. H., Nassor, N. K., Mboera, L. E. G., Ngadaya, E., Mangesho, P., Bakari, M., Urassa, M., Seif, M., Tarimo, C., Masemo, A., Mmbaga, B. T., O'Sullivan, N., McCoy, D., Russo, G.
10.1101/2023.01.11.23284423 — Posted: 2023-01-11
Interleukin-1 receptor antagonist gene (IL1RN) variants modulate the cytokine release syndrome and mortality of SARS-CoV-2
Attur, M. G., Petrilli, C. M., Adhikari, S., Iturrate, E., Li, X., Tuminello, S., Hu, N., Chakravarti, A., Beck, D. B., Abramson, S. B.
10.1101/2023.01.09.23284348 — Posted: 2023-01-11
A cross sectional survey examining the association of clinician characteristics with perceived changes in cervical cancer screening and colposcopy practice during the COVID-19 pandemic
Fuzzell, L., Brownstein, N. C., Fontenot, H. B., Lake, P., Michel, A., Whitmer, A., Rossi, S. L., McIntyre, M., Vadaparampil, S. T., Perkins, R. B.
10.1101/2023.01.11.23284437 — Posted: 2023-01-11
Country Learning on Maintaining Quality Essential Health Services (EHS) during COVID-19 in Timor-Leste: A mixed methods qualitative analysis
Kleine Bingham, M., Rangel, G., Sarakbi, D., Kelleher, T., Mensah Abrampah, N., Neilson, M., Bodson, O., White, P., Bothra, V., de Carvalho, H. M., da C.A. Pinto, F., Syed, S. B.
10.1101/2023.01.11.23284424 — Posted: 2023-01-11
Prior SARS-CoV-2 Infection and COVID-19 Vaccine Effectiveness against Outpatient Illness during Widespread Circulation of SARS-CoV-2 Omicron Variant, US Flu VE Network
Tartof, S. Y., Xie, F., Yadav, R., Wernli, K. J., Martin, E. T., Belongia, E. A., Gaglani, M., Zimmerman, R., Talbot, H. K., Thornburg, N., Flannery, B., US Flu VE Network Investigators, , Chung, J.
10.1101/2023.01.10.23284397 — Posted: 2023-01-11

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).